Get to know our clinical trials

Clinical trial of FOCAL pulsed-field ablation using the TactiFLEX SE catheter and the Volt generator for the treatment of paroxysmal atrial fibrillation

THE AIM OF THIS CLINICAL STUDY IS TO DEMONSTRATE THAT THE TACTIFLEX PFA SYSTEM IS SAFE AND EFFECTIVE FOR TREATING ATRIAL FIBRILLATION THROUGH ABLATION.

La imagen muestra al Dr. Ignacio García-Bolao, especialista en Cardiología de la Clínica Universidad de Navarra. El Dr. García-Bolao se dedica al diagnóstico y tratamiento de enfermedades cardiovasculares, y en especial, al estudio y tratamiento de las arritmias cardiacas.
Dr. Ignacio García Bolao Curriculum
Director Cardiology Department
Navarre headquarters
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • A STUDY OF FOCAL PULSED-FIELD ABLATION USING THE TACTIFLEX SE CATHETER AND THE VOLT GENERATOR FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION
  • Code EudraCT: .
  • Protocol number: ABT-CIP-10518
  • Promoter: Abbott Laboratories, S.A.
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION